Pfiz­er and BioN­Tech look to toss Mod­er­na patent suit, call­ing claims 'unen­force­able'

Pfiz­er and BioN­Tech took a swing at Mod­er­na’s Covid-19 patent claims in Mass­a­chu­setts fed­er­al court on Mon­day, call­ing them “in­valid,” “over­broad” and “un­en­force­able.”

The de­fen­dants al­so filed coun­ter­claims against the Cam­bridge, MA-based biotech, seek­ing a dis­missal of the case, re­cov­ery of court fees and an of­fi­cial judg­ment in­val­i­dat­ing Mod­er­na’s claims.

Mod­er­na sued Pfiz­er and BioN­Tech back in Au­gust, al­leg­ing that the part­ners’ Covid-19 vac­cine Comir­naty copied parts of Mod­er­na’s vac­cine tech­nol­o­gy patent­ed be­fore the pan­dem­ic, when it was de­vel­op­ing an mR­NA vac­cine for MERS, an­oth­er res­pi­ra­to­ry ill­ness.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER